Publicaciones en las que colabora con María Purificación Vindel Cañas (18)

2016

  1. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

2015

  1. In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response

    Mucosal Immunology, Vol. 8, Núm. 2, pp. 362-371

  2. Response to "In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response"

    Mucosal Immunology

2014

  1. Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in Spain: 2004-12

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 2913-2919

2011

  1. Molecular analysis of community-acquired methicillin-susceptible and resistant Staphylococcus aureus isolates recovered from bacteraemic and osteomyelitis infections in children from Tunisia

    Clinical Microbiology and Infection, Vol. 17, Núm. 7, pp. 1020-1026

2009

  1. Methicillin-resistant Staphylococcus aureus in Spain: Molecular epidemiology and utility of different typing methods

    Journal of Clinical Microbiology, Vol. 47, Núm. 6, pp. 1620-1627

2008

  1. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates

    Diagnostic Microbiology and Infectious Disease, Vol. 61, Núm. 2, pp. 143-149

  2. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: A multicentre prevalence study (2002)

    Clinical Microbiology and Infection, Vol. 13, Núm. 3, pp. 250-256

2005

  1. Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 1, pp. 220-223

2004

  1. Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: Five nationwide prevalence studies, 1986 to 2002

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 11, pp. 4240-4245

  2. High Genetic Diversity among Stenotrophomonas maltophilia Strains Despite Their Originating at a Single Hospital

    Journal of Clinical Microbiology, Vol. 42, Núm. 2, pp. 693-699

2003

  1. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates

    Pediatric Pulmonology, Vol. 35, Núm. 2, pp. 99-107

  2. Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales Españoles

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 1, pp. 41-52

2002

  1. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 3, pp. 665-671

2001

  1. Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 5, pp. 1581-1584

  2. Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998

    Emerging Infectious Diseases, Vol. 7, Núm. 1, pp. 113-122

1999

  1. Comparative in vitro activity of quinolones against stenotrophomonas maltophilia

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 12, pp. 908-911